Corrigendum to "Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study".
Ther Adv Psychopharmacol May 19, 2026 correction DOI: 10.1177/20451253261452482 (opens in new tab) via PubMed Central
Study at a glance
| Characteristics | Corrigendum |
|---|---|
| Population | Treatment-resistant depression |
| Key finding | Corrigendum to a 5-year observational study on intranasal esketamine dosing patterns and clinical outcomes; no new findings. |
Abstract
Corrigendum to "Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study".